Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

For important updates on recent policy changes, please click here for more details.

Merck
CN

Protein Stabilizers

Parenteral formulations using protein stabilizers

Sterile liquid applications demand excipients of the highest quality, purity, and reliability. Our comprehensive portfolio of high-quality pharmaceutical excipients offers everything you need for your medicinal drug product, backed by the regulatory and quality support of the Emprove® Program to streamline approval preparation and accelerate your processes. When your goal is a successful journey to market for small- or large-volume parenteral applications, you can count on our industry know-how, regulatory expertise, and comprehensive documentation to help you go forward with confidence.  


High-quality Protein Stabilizers for Biomolecules

Specifically developed for high-risk applications, our portfolio of high-quality sugars, polyols, amino acids, and surfactants simplifies selection when you face critical challenges such as preventing aggregation during manufacturing. Benefits include:

  • Low endotoxin and microbial limits
  • Elemental Impurity Information according to ICH Q3D
  • Emprove® Program and documentation supporting risk assessment
  • Emprove® Expert GMP-grade products for high-risk applications

Products

Sort by Relevance
Showing 1-20 of 36
Change View
Showing 1-20 of 36
Compare
Product Number
Product Name
Product Description
Pricing
You have viewed 1-20 of 36 results
Page 1 of 2

Related Product Resources

Page 1 of 3

Do you want to increase your efficiency during your Downstream Process?

The production of antibodies and Fc-fusion proteins involves several downstream processing unit operations. The widely used purification template with Protein A chromatography, virus inactivation at low pH, and subsequent ion exchange chromatography steps is mostly able to remove impurities like aggregates, host-cell proteins, and viruses, which could affect the safety and efficacy of the product.

The low pH elution during Protein A chromatography, as well as during virus inactivation may induce aggregation. Preventing protein aggregation during these unit operations instead of removing the multimeric forms during subsequent polishing steps would be a more efficient strategy. Curious to learn more how the aggregation levels in the final product formulation can be minimized by excipients? Click on below image to check out our new Poster “Application of Excipients in Downstream Processing”.

mAbs Workflow




Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?